rs1064794253
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_058216.3(RAD51C):c.308_310delTCT(p.Phe103del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00000137 in 1,461,872 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_058216.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461872Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 727234
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:2
In-frame deletion of 1 amino acid in a non-repeat region; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; Located in the critical ATPase domain (Miller 2004); Observed in an individual with a personal and/or family history of breast cancer (Thompson 2012); This variant is associated with the following publications: (PMID: 14704354, 21990120) -
Curator: Arleen D. Auerbach. Submitter to LOVD: Ian Campbell. -
Hereditary cancer-predisposing syndrome Uncertain:2
The c.308_310delTCT variant (also known as p.F103del) is located in coding exon 2 of the RAD51C gene. This variant results from an in-frame TCT deletion at nucleotide positions 308 to 310. This results in the in-frame deletion of a phenylalanine at codon 103. This alteration has been reported in 1 of 1053 hereditary breast cancer families and was not seen in 427 controls (Thompson ER et al. Hum. Mutat., 2012 Jan;33:95-9). The deleted amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
This variant causes an in-frame deletion of 1 amino acid of the RAD51C protein. Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in one breast cancer family (PMID: 21990120). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Fanconi anemia complementation group O Uncertain:1
This variant, c.308_310del, results in the deletion of 1 amino acid(s) of the RAD51C protein (p.Phe103del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with a personal and/or family history of breast cancer (PMID: 21990120). ClinVar contains an entry for this variant (Variation ID: 420040). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at